View Older Stories View More Recent Stories

Feb 26, 2026 12:21PM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Feb 26, 2026 07:38AM Rhythm Pharmaceuticals (RYTM) Tops Q4 EPS by 9c

Feb 18, 2026 04:30PM RBC Capital Starts Rhythm Pharmaceuticals (RYTM) at Outperform; 'Set' Up to Hit High Notes in Rare Obesity'

Jan 20, 2026 06:40AM Rhythm Pharmaceuticals (RYTM) PT Raised to $125 at H.C. Wainwright

Jan 9, 2026 01:08PM Rhythm Pharmaceuticals (RYTM) PT Raised to $130 at TD Cowen

Jan 9, 2026 08:02AM Rhythm Pharmaceuticals reports $57M Q4 revenue, 50% annual growth

Dec 22, 2025 07:10AM Rhythm Pharmaceuticals (RYTM) PT Raised to $123 at H.C. Wainwright

Dec 17, 2025 06:45AM Rhythm Pharmaceuticals (RYTM) PT Raised to $140 at Guggenheim

Dec 12, 2025 06:54AM Rhythm Pharmaceuticals (RYTM) PT Raised to $141 at Canaccord Genuity

Dec 12, 2025 04:55AM Rhythm Pharmaceuticals (RYTM) PT Raised to $167 at Citizens

Dec 12, 2025 03:32AM Rhythm Pharmaceuticals (RYTM) PT Raised to $157 at Goldman Sachs

Dec 11, 2025 02:11PM TD Cowen Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Dec 11, 2025 12:58PM Rhythm Pharmaceuticals (RYTM) PT Raised to $150 at Morgan Stanley

Dec 11, 2025 12:23PM Raymond James on Aardvark (AARD): 'we think ARD-101’s value proposition as potentially best-in-class

Dec 11, 2025 11:36AM Rhythm Pharmaceuticals (RYTM) PT Raised to $145 at Needham

Nov 25, 2025 04:02AM Citi Starts Rhythm Pharmaceuticals (RYTM) at Buy, PT $136

Nov 7, 2025 02:06PM Rhythm Pharmaceuticals (RYTM) PT Lowered to $141 at Goldman Sachs

Nov 7, 2025 07:30AM Rhythm Pharmaceuticals faces FDA review delay for obesity drug

Nov 5, 2025 04:02PM Rhythm gets public reimbursement for IMCIVREE in five Canadian provinces

Nov 5, 2025 02:42AM Oppenheimer Downgrades Rhythm Pharmaceuticals (RYTM) to Perform

Nov 4, 2025 07:17AM Rhythm Pharmaceuticals (RYTM) Misses Q3 EPS by 11c, provides guidance

Sep 29, 2025 06:56AM Rhythm Pharmaceuticals (RYTM) PT Raised to $110 at H.C. Wainwright

Sep 25, 2025 06:50AM Stifel Reiterates Buy Rating on Rhythm Pharmaceuticals (RYTM)

Sep 25, 2025 05:12AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Sep 25, 2025 04:02AM Rhythm Pharmaceuticals (RYTM) PT Raised to $157 at Goldman Sachs

Sep 24, 2025 03:42PM Rhythm Pharmaceuticals (RYTM) PT Raised to $122 at Morgan Stanley

Sep 23, 2025 04:19AM Citizens JMP Reiterates Market Outperform Rating on Rapport Therapeutics (RAPP)

Sep 23, 2025 04:18AM Citizens JMP Reiterates Market Outperform Rating on Abivax (ABVX)

Aug 21, 2025 04:09AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

Aug 20, 2025 04:01PM FDA accepts Rhythm Pharmaceuticals' setmelanotide filing for rare obesity

Aug 7, 2025 07:18AM Rhythm Pharmaceuticals (RYTM) PT Raised to $100 at H.C. Wainwright

Aug 6, 2025 04:15AM Rhythm Pharmaceuticals (RYTM) PT Raised to $135 at Citizens JMP

Aug 5, 2025 12:39PM Rhythm Pharmaceuticals (RYTM) PT Raised to $110 at TD Cowen

Aug 5, 2025 07:32AM Rhythm Pharmaceuticals (RYTM) Misses Q2 EPS by 8c

Jul 18, 2025 06:20AM Rhythm Pharmaceuticals (RYTM) PT Raised to $105 at Canaccord Genuity

Jul 15, 2025 06:06AM Rhythm Pharmaceuticals (RYTM) PT Raised to $109 at BofA Securities

Jul 14, 2025 05:23AM Citizens JMP Upgrades Rhythm Pharmaceuticals (RYTM) to Market Outperform

Jul 10, 2025 07:42AM Morgan Stanley Reiterates Overweight Rating on Rhythm Pharmaceuticals (RYTM)

Jul 10, 2025 06:25AM Goldman Sachs Resumes Rhythm Pharmaceuticals (RYTM) at Buy

Jul 10, 2025 06:22AM Rhythm Pharmaceuticals prices $175 million stock offering at $85 per share

Jul 10, 2025 06:16AM Rhythm Pharmaceuticals (RYTM) PT Raised to $110 at Oppenheimer

Jul 9, 2025 04:18PM Rhythm Pharmaceuticals (RYTM) PT Raised to $102 at Leerink Partners

Jul 9, 2025 04:16PM Rhythm Pharmaceuticals announces $150 million stock offering

Jul 9, 2025 12:47PM Rhythm Pharmaceuticals (RYTM) PT Raised to $123 at Stifel

Jul 9, 2025 12:45PM Rhythm Pharmaceuticals (RYTM) PT Raised to $95 at BofA Securities

Jul 9, 2025 09:15AM Stifel on Rhythm Pharmaceuticals (RYTM): 'Bivamelagon Data Look Very Solid and Meet/Exceed Our Bar'

Jul 9, 2025 08:00AM Rhythm Pharmaceuticals' bivamelagon shows BMI reduction in obesity trial

Jul 8, 2025 04:03PM Rhythm Pharmaceuticals to report phase 2 trial results for obesity drug

Jul 7, 2025 06:19AM Leerink Partners Starts Rhythm Pharmaceuticals (RYTM) at Outperform

Jul 2, 2025 04:07AM Citizens JMP Reiterates Market Outperform Rating on Rhythm Pharmaceuticals (RYTM)

View More Recent Stories View Older Stories